Drugs to limit Zika virus infection and implication for maternal-fetal health
Although the placenta has robust defense mechanisms that protect the fetus from a viral infection, some viruses can manipulate or evade these mechanisms and disrupt physiology or cross the placental barrier. It is well established that the Zika virus is capable of vertical transmission from mother t...
Main Authors: | Ankur Kumar, Deepak Kumar, Joyce Jose, Rajanish Giri, Indira U. Mysorekar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Virology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fviro.2022.928599/full |
Similar Items
-
Corrigendum: Advancement in the development of therapeutics against Zika virus infection
by: Kangchen Li, et al.
Published: (2022-08-01) -
Discovery of Bispecific Lead Compounds from <i>Azadirachta indica</i> against ZIKA NS2B-NS3 Protease and NS5 RNA Dependent RNA Polymerase Using Molecular Simulations
by: Sanjay Kumar, et al.
Published: (2022-04-01) -
In silico testing of flavonoids as potential inhibitors of protease and helicase domains of dengue and Zika viruses
by: Omar Cruz-Arreola, et al.
Published: (2022-08-01) -
Structure-Based Virtual Screening: Identification of a Novel NS2B-NS3 Protease Inhibitor with Potent Antiviral Activity against Zika and Dengue Viruses
by: Hye Jin Shin, et al.
Published: (2021-03-01) -
In silico studies of bioactive compounds from Alpinia officinarum as inhibitors of Zika virus protease
by: Damilola J. Gbore, et al.
Published: (2023-01-01)